Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
78.4M
-
Number of holders
-
124
-
Total 13F shares, excl. options
-
56.8M
-
Shares change
-
+2.22M
-
Total reported value, excl. options
-
$971M
-
Value change
-
+$32.5M
-
Put/Call ratio
-
0.78
-
Number of buys
-
59
-
Number of sells
-
-62
-
Price
-
$17.11
Significant Holders of Replimune Group, Inc. - COMMON STOCK (REPL) as of Q3 2023
169 filings reported holding REPL - Replimune Group, Inc. - COMMON STOCK as of Q3 2023.
Replimune Group, Inc. - COMMON STOCK (REPL) has 124 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 56.8M shares
of 78.4M outstanding shares and own 72.47% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (5.79M shares), BAKER BROS. ADVISORS LP (4.58M shares), Redmile Group, LLC (4.16M shares), BlackRock Inc. (3.96M shares), Omega Fund Management, LLC (3M shares), VANGUARD GROUP INC (2.6M shares), STATE STREET CORP (2.37M shares), JANUS HENDERSON GROUP PLC (2.17M shares), BVF INC/IL (2.14M shares), and Atlas Venture Life Science Advisors, LLC (2.1M shares).
This table shows the top 124 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.